Progress and Opportunities in Molecular Pathological Epidemiology of Colorectal Premalignant Lesions

[1]  F. Coppedè.  The role of epigenetics in colorectal cancer , 2014, Expert review of gastroenterology & hepatology.

[2]  J. Meyerhardt,et al.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology , 2014, Oncogene.

[3]  R. Malekzadeh,et al.  Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. , 2014, World journal of gastroenterology.

[4]  I. Zlobec,et al.  Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high‐level CpG Island methylator phenotype and mismatch repair‐deficiency , 2014, International journal of cancer.

[5]  C. Amos,et al.  Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations , 2014, Clinical chemistry and laboratory medicine.

[6]  N. Shaheen.  Editorial: What Is Behind the Remarkable Increase in Esophageal Adenocarcinoma? , 2014, The American Journal of Gastroenterology.

[7]  Z. Qian,et al.  HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma , 2014, British Journal of Cancer.

[8]  C. Masselon,et al.  Beyond laser microdissection technology: follow the yellow brick road for cancer research. , 2014, American journal of cancer research.

[9]  F. Marincola,et al.  Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours , 2013, The Journal of pathology.

[10]  C. Marsit,et al.  Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon , 2014, Modern Pathology.

[11]  K. Jirström,et al.  Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability , 2014, BMC Cancer.

[12]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[13]  E. Livingston,et al.  New insights on bariatric surgery outcomes. , 2013, JAMA.

[14]  N. Ajami,et al.  Potential role of gastrointestinal microbiota composition in prostate cancer risk , 2013, Infectious Agents and Cancer.

[15]  C. Yau,et al.  Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations , 2013, The American Journal of Gastroenterology.

[16]  R. Palmqvist,et al.  The Association of Immune Cell Infiltration and Prognosis in Colorectal Cancer , 2013, Current Colorectal Cancer Reports.

[17]  M. Kloor,et al.  Body Mass Index and Microsatellite Instability in Colorectal Cancer: A Population-based Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[18]  Reiko Nishihara,et al.  Long-term colorectal-cancer incidence and mortality after lower endoscopy. , 2013, The New England journal of medicine.

[19]  C. Carlson,et al.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. , 2013, International journal of molecular epidemiology and genetics.

[20]  K. Jirström,et al.  Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study , 2013, Biology of Sex Differences.

[21]  P. Zauber,et al.  Similarities of molecular genetic changes in synchronous and metachronous colorectal cancers are limited and related to the cancers' proximities to each other. , 2013, The Journal of molecular diagnostics : JMD.

[22]  F. Grizzi,et al.  Immune cells: plastic players along colorectal cancer progression , 2013, Journal of cellular and molecular medicine.

[23]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[24]  Aung Ko Win,et al.  Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability: The Colon Cancer Family Registry , 2013, Diseases of the colon and rectum.

[25]  J. Cerhan,et al.  Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women. , 2013, Gastroenterology.

[26]  F. Bazzoli,et al.  Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention , 2013, International journal of molecular sciences.

[27]  N. Cho,et al.  Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location , 2013, British Journal of Cancer.

[28]  T. Smyrk,et al.  Serrated colon polyps as precursors to colorectal cancer. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  E. Giovannucci,et al.  Original Contribution A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification , 2013 .

[30]  D. Knol,et al.  Tracking the Molecular Features of Nonpolypoid Colorectal Neoplasms: A Systematic Review and Meta‐Analysis , 2013 .

[31]  Fazlul H. Sarkar,et al.  Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy , 2013, International journal of molecular sciences.

[32]  Molin Wang,et al.  Aspirin use and risk of colorectal cancer according to BRAF mutation status. , 2013, JAMA.

[33]  Aung Ko Win,et al.  PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival , 2013, PloS one.

[34]  Kebin Liu,et al.  Epigenetics and Colorectal Cancer Pathogenesis , 2013, Cancers.

[35]  M. Ribeiro,et al.  MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. , 2013, World journal of gastroenterology.

[36]  J. Potter,et al.  Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. , 2013, Cancer research.

[37]  J. Meyerhardt,et al.  Physical Activity, Tumor PTGS2 Expression, and Survival in Patients with Colorectal Cancer , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[38]  Kjetil Søreide,et al.  Molecular Pathways and Cellular Metabolism in Colorectal Cancer , 2013, Digestive Surgery.

[39]  E. Kuipers,et al.  Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. , 2013, Gastrointestinal endoscopy.

[40]  John D Potter,et al.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. , 2013, American journal of epidemiology.

[41]  N. Caporaso.  Why Precursors Matter , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[42]  Aung Ko Win,et al.  KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers , 2013, British Journal of Cancer.

[43]  Aung Ko Win,et al.  Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[44]  Jiri Bartek,et al.  Replication stress links structural and numerical cancer chromosomal instability , 2013, Nature.

[45]  S. Bonin,et al.  Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision , 2013, BMC Gastroenterology.

[46]  Jenn-Kang Hwang,et al.  Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations , 2013, PloS one.

[47]  B. Leggett,et al.  The serrated pathway to colorectal carcinoma: current concepts and challenges , 2013, Histopathology.

[48]  H. Nan,et al.  Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival. , 2013, Carcinogenesis.

[49]  Aung Ko Win,et al.  Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features , 2013, Modern Pathology.

[50]  I. Tomlinson,et al.  Whole-genome methylation analysis of benign and malignant colorectal tumours , 2013, The Journal of pathology.

[51]  Alexander Meissner,et al.  Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease , 2013, Modern Pathology.

[52]  P. A. van den Brandt,et al.  The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach , 2013, Current Nutrition Reports.

[53]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[54]  R. Kaliaperumal,et al.  Conventional and nanotechniques for DNA methylation profiling. , 2013, The Journal of molecular diagnostics : JMD.

[55]  D. Hewett,et al.  Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management , 2012, Journal of Gastroenterology.

[56]  A. Goel,et al.  Epigenetics of colorectal cancer. , 2012, Gastroenterology.

[57]  J. Hardwick,et al.  Cholesterol metabolism and colorectal cancers. , 2012, Current opinion in pharmacology.

[58]  T. Sellers,et al.  Integrative cancer epidemiology--the next generation. , 2012, Cancer discovery.

[59]  N. Blin,et al.  Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[60]  P. Wei,et al.  The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis , 2012, Clinical Cancer Research.

[61]  T. Golub,et al.  Expression Profiling of Archival Tumors for Long-term Health Studies , 2012, Clinical Cancer Research.

[62]  M. Toyota,et al.  Tumorigenesis and Neoplastic Progression Molecular Dissection of Premalignant Colorectal Lesions Reveals Early Onset of the CpG Island Methylator Phenotype , 2012 .

[63]  R. Luben,et al.  Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC‐Norfolk study , 2012, The Journal of pathology.

[64]  I. Zlobec,et al.  The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer , 2012, Histopathology.

[65]  Reiko Nishihara,et al.  Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. , 2012, The New England journal of medicine.

[66]  L. Kuller.  Invited commentary: the 21st century epidemiologist--a need for different training? , 2012, American journal of epidemiology.

[67]  A. Beck,et al.  Ogino et Al. Respond to "the 21st century epidemiologist". , 2012, American journal of epidemiology.

[68]  Andrew H. Beck,et al.  Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. , 2012, American journal of epidemiology.

[69]  R. Palmqvist,et al.  The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer , 2012, PloS one.

[70]  Greg Yothers,et al.  Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value , 2012, Clinical Cancer Research.

[71]  F. Marincola,et al.  Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.

[72]  R. Ali,et al.  Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms , 2012, Nature Reviews Clinical Oncology.

[73]  Ronglai Shen,et al.  Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers , 2012, Clinical Cancer Research.

[74]  C. Boland,et al.  A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer , 2012, PloS one.

[75]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[76]  Charles J. Kahi,et al.  Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel , 2012, The American Journal of Gastroenterology.

[77]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[78]  John D Potter,et al.  BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[79]  Y. Pawitan,et al.  Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X , 2012, Modern Pathology.

[80]  R. Goldbohm,et al.  Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. , 2012, International journal of epidemiology.

[81]  E. Giovannucci,et al.  Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. , 2012, International journal of epidemiology.

[82]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[83]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[84]  Reiko Nishihara,et al.  Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers , 2012, Clinical Cancer Research.

[85]  B. Parsons,et al.  Hotspot oncomutations: implications for personalized cancer treatment , 2012, Expert review of molecular diagnostics.

[86]  J. Koshiol,et al.  Can tissue-based immune markers be used for studying the natural history of cancer? , 2012, Annals of epidemiology.

[87]  Shuji Ogino,et al.  How many molecular subtypes? Implications of the unique tumor principle in personalized medicine , 2012, Expert review of molecular diagnostics.

[88]  T. Bekaii-Saab,et al.  CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer , 2012, Chemotherapy research and practice.

[89]  A. Frankel.  Formalin fixation in the ‘‐omics’ era: a primer for the surgeon‐scientist , 2012, ANZ journal of surgery.

[90]  Shuji Ogino,et al.  Colorectal cancer: a tale of two sides or a continuum? , 2012, Gut.

[91]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[92]  Charles J. Kahi,et al.  High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. , 2012, Gastrointestinal endoscopy.

[93]  S. Ogino,et al.  Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. , 2012, The Journal of molecular diagnostics : JMD.

[94]  S. Dry,et al.  Stuck between a scalpel and a rock, or molecular pathology and legal-ethical issues in use of tissues for clinical care and research: what must a pathologist know? , 2012, American journal of clinical pathology.

[95]  Reiko Nishihara,et al.  Imaging , Diagnosis , Prognosis Prognostic Role of PIK 3 CA Mutation in Colorectal Cancer : Cohort Study and Literature Review , 2012 .

[96]  J. Cerhan,et al.  Postmenopausal Hormone Therapy and Colorectal Cancer Risk in Relation to Somatic KRAS Mutation Status among Older Women , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[97]  R. Ettarh.  Colorectal Cancer Biology - From Genes to Tumor , 2012 .

[98]  F. Grizzi,et al.  Adaptive and Innate Immunity, Non Clonal Players in Colorectal Cancer Progression , 2012 .

[99]  M. Heymans,et al.  Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer , 2012, Annals of Surgical Oncology.

[100]  Shu Wang,et al.  Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation , 2012, Nature Communications.

[101]  L. Terracciano,et al.  Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer , 2011, Front. Oncol..

[102]  J. Meyerhardt,et al.  Energy in and energy out: what matters for survivors of colorectal cancer? , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  P. A. van den Brandt,et al.  The CpG island methylator phenotype in colorectal cancer: progress and problems. , 2012, Biochimica et biophysica acta.

[104]  P. Laird,et al.  Genome-scale analysis of aberrant DNA methylation in colorectal cancer. , 2012, Genome research.

[105]  Y. Sakamoto,et al.  Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma , 2012, Annals of Surgical Oncology.

[106]  William M. Grady,et al.  Epigenetics and colorectal cancer , 2011, Nature Reviews Gastroenterology &Hepatology.

[107]  T. Graeber,et al.  A Metaproteomic Approach to Study Human-Microbial Ecosystems at the Mucosal Luminal Interface , 2011, PloS one.

[108]  I. Zlobec,et al.  Comprehensive analysis of CpG island methylator phenotype (CIMP)‐high, ‐low, and ‐negative colorectal cancers based on protein marker expression and molecular features , 2011, The Journal of pathology.

[109]  P. Febbo,et al.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[110]  J. Herman,et al.  Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract , 2011, International journal of cancer.

[111]  V. Guillem,et al.  APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study , 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[112]  G. Dranoff,et al.  Cancer immunology—analysis of host and tumor factors for personalized medicine , 2011, Nature Reviews Clinical Oncology.

[113]  J. Carethers.  One colon lumen but two organs. , 2011, Gastroenterology.

[114]  R. Klopfleisch,et al.  Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. , 2011, Histology and histopathology.

[115]  Joong Bae Ahn,et al.  DNA methylation predicts recurrence from resected stage III proximal colon cancer , 2011, Cancer.

[116]  R. Palmqvist,et al.  Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor , 2011, Modern Pathology.

[117]  Shuji Ogino,et al.  Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. , 2011, JAMA.

[118]  R. Turner,et al.  LINE-1 Hypomethylation During Primary Colon Cancer Progression , 2011, PloS one.

[119]  Martha L. Slattery,et al.  CpG Island Methylation in Colorectal Cancer: Past, Present and Future , 2011, Pathology research international.

[120]  N. Kitkumthorn,et al.  Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications , 2011, Clinical Epigenetics.

[121]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[122]  R. Goldbohm,et al.  Body Size, Physical Activity and Risk of Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP) , 2011, PloS one.

[123]  C. Ulrich,et al.  Nutrients in Folate-Mediated, One-Carbon Metabolism and the Risk of Rectal Tumors in Men and Women , 2011, Nutrition and cancer.

[124]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[125]  M. O'brien,et al.  The Clinical Significance of Serrated Polyps , 2011, The American Journal of Gastroenterology.

[126]  J. Mason,et al.  Regulatory and ethical issues on the utilization of FFPE tissues in research. , 2011, Methods in molecular biology.

[127]  L. Terracciano,et al.  Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer , 2010, International journal of cancer.

[128]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[129]  S. Tavaré,et al.  Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression , 2010, Gut.

[130]  E. Giovannucci,et al.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field , 2010, Gut.

[131]  E. Dogliotti,et al.  Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. , 2010, European journal of cancer.

[132]  M. O'brien,et al.  Variation in the Detection of Serrated Polyps in an Average Risk Colorectal Cancer Screening Cohort , 2010, The American Journal of Gastroenterology.

[133]  J. Cerhan,et al.  Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. , 2010, Journal of the National Cancer Institute.

[134]  L. Terracciano,et al.  Clinicopathological and protein characterization of BRAF‐ and K‐RAS‐mutated colorectal cancer and implications for prognosis , 2010, International journal of cancer.

[135]  J. Bond,et al.  CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle , 2010, The American Journal of Gastroenterology.

[136]  Shuji Ogino,et al.  Editorial Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: the Evolving Field of Molecular Pathological Epidemiology , 2022 .

[137]  R. Palmqvist,et al.  The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status , 2010, Clinical Cancer Research.

[138]  S. Gruber,et al.  Smoking, Gender, and Ethnicity Predict Somatic BRAF Mutations in Colorectal Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[139]  R. Wolff,et al.  Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. , 2010, Cancer research.

[140]  G. Colditz.  Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control , 2010, Cancer Causes & Control.

[141]  N. Cho,et al.  Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers , 2009, Virchows Archiv.

[142]  R. Wolff,et al.  Somatic alterations, metabolizing genes and smoking in rectal cancer , 2009, International journal of cancer.

[143]  Shuji Ogino,et al.  Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. , 2009, Neoplasia.

[144]  Shuji Ogino,et al.  JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. , 2009, Neoplasia.

[145]  M. Loda,et al.  Cohort study of fatty acid synthase expression and patient survival in colon cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[146]  Shuji Ogino,et al.  A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. , 2008, Journal of the National Cancer Institute.

[147]  John Quackenbush,et al.  Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample , 2008, PloS one.

[148]  P. Laurent-Puig,et al.  Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. , 2008, Cancer research.

[149]  Shuji Ogino,et al.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer , 2008, Gut.

[150]  Michael R. Green,et al.  Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.

[151]  S. Ogino,et al.  Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.

[152]  I. Tomlinson,et al.  Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas , 2007, The Journal of pathology.

[153]  S. Gruber,et al.  Genetic variation in 8q24 associated with risk of colorectal cancer , 2007, Cancer biology & therapy.

[154]  Emily J. Greenspan,et al.  Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. , 2007, Cancer research.

[155]  Naoshi Nishida,et al.  High copy amplification of the aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers , 2007, Cancer biology & therapy.

[156]  J. Meyerhardt,et al.  Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer , 2007, Gut.

[157]  J. Willson,et al.  Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis , 2007, Molecular Cancer Therapeutics.

[158]  M. van Engeland,et al.  Dietary Folate Intake in Combination with MTHFR C677T Genotype and Promoter Methylation of Tumor Suppressor and DNA Repair Genes in Sporadic Colorectal Adenomas , 2007, Cancer Epidemiology Biomarkers & Prevention.

[159]  Jennifer Herrick,et al.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. , 2006, Journal of the National Cancer Institute.

[160]  M. Loda,et al.  CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.

[161]  D. Pearson,et al.  Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells , 2006, Laboratory Investigation.

[162]  Chiu-Hsieh Hsu,et al.  Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics , 2006, Cancer Epidemiology Biomarkers & Prevention.

[163]  M. Weijenberg,et al.  Diet, lifestyle and risk of K‐ras mutation‐positive and ‐negative colorectal adenomas , 2006, International journal of cancer.

[164]  W. Gerald,et al.  Gene expression profiling in single cells within tissue , 2005, Nature Methods.

[165]  C. Amos,et al.  The Hamartomatous Polyposis Syndromes: A Clinical and Molecular Review , 2005, The American Journal of Gastroenterology.

[166]  N. Matsubara,et al.  BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum , 2004, Gut.

[167]  F. Bazzoli,et al.  Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. , 2003, Cancer research.

[168]  Jahn M. Nesland,et al.  Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.

[169]  B. Iacopetta.  Are there two sides to colorectal cancer? , 2002, International journal of cancer.

[170]  D. Alberts,et al.  Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. , 2001, Gastroenterology.

[171]  H. Clevers,et al.  Mutations in the APC tumour suppressor gene cause chromosomal instability , 2001, Nature Cell Biology.

[172]  B. Leggett,et al.  Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. , 2001, Cancer research.

[173]  D. Alberts,et al.  Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas. , 1999, Cancer research.

[174]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[175]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[176]  J. Bufill,et al.  Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. , 1990, Annals of internal medicine.

[177]  A. Zauber,et al.  The National Polyp Study , 1990 .

[178]  A. Zauber,et al.  The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. , 1990, Gastroenterology.

[179]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[180]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.